BioVie Inc.
BIVI
$0.8502
$0.01021.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.26M | 8.98M | 8.85M | 8.79M | 9.34M |
| Depreciation & Amortization | 229.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.94M | 25.43M | 32.18M | 38.37M | 44.41M |
| Operating Income | -23.94M | -25.43M | -32.18M | -38.37M | -44.41M |
| Income Before Tax | -24.27M | -25.56M | -32.12M | -36.29M | -43.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.27 | -25.56 | -32.12 | -36.29 | -43.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.27M | -25.56M | -32.12M | -36.29M | -43.27M |
| EBIT | -23.94M | -25.43M | -32.18M | -38.37M | -44.41M |
| EBITDA | -23.71M | -25.20M | -31.95M | -38.14M | -44.18M |
| EPS Basic | -3.96 | -5.71 | -7.92 | -9.63 | -11.89 |
| Normalized Basic EPS | -2.32 | -3.41 | -4.83 | -5.89 | -7.43 |
| EPS Diluted | -3.99 | -5.73 | -7.95 | -9.63 | -11.93 |
| Normalized Diluted EPS | -2.32 | -3.41 | -4.83 | -5.89 | -7.43 |
| Average Basic Shares Outstanding | 32.71M | 20.81M | 18.08M | 15.60M | 14.65M |
| Average Diluted Shares Outstanding | 32.71M | 20.81M | 18.08M | 15.60M | 14.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |